S
Product director, diabetes franchise, GlaxoSmithKline
BORN IN: Belfast, Ireland
PEOPLE ARE: "Your long term strategic advantage"
On the tough times ahead:
In five or 10 years, some companies will be here and some will not—and it is the leadership of the company that will determine that. The irony is that it will require a lot of investment in both capital and human resources to be successful at a time when maybe those investments are more likely to drop. It is going to take courage to figure out just what are the key issues, where the company needs to go, and then make those expenditures into the long term health of the company.
Sean McLoughlin
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.